Cargando…
Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
Autores principales: | Moore, Angela Yen, Cepica, Tyler, Maberry, Samanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014316/ https://www.ncbi.nlm.nih.gov/pubmed/35445147 http://dx.doi.org/10.1016/j.jdcr.2022.02.025 |
Ejemplares similares
-
Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib
por: Kim, Sa Rang, et al.
Publicado: (2021) -
Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation()()
por: Komnitski, Melpone, et al.
Publicado: (2020) -
Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis
por: Tajalli, Mahroo, et al.
Publicado: (2020) -
Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
por: Berbert Ferreira, Sineida, et al.
Publicado: (2021) -
Antibodies to normal human melanocytes in vitiligo
Publicado: (1983)